BIOLOGICAL · Unmapped registry intervention
PDA-002
Find medicine records ·
Find other trials using this name
Clinical trial
Study of PDA-002 in Subjects With Peripheral Arterial Disease and Diabetic Foot Ulcers
NCT01859117
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedStudy of PDA-002 in Subjects With Peripheral Arterial Disease and Diabetic Foot Ulcers
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Diabetic Foot Ulcerunresolved
Interventions
PDA-002BIOLOGICAL
Sponsors & collaborators
Celularity Incorporatedlead sponsor
Mapped research locations
Los AngelesCalifornia, United States1San AntonioTexas, United States1PhoenixArizona, United States1MinneapolisMinnesota, United States1Oklahoma CityOklahoma, United States1Chapel HillNorth Carolina, United States1MadisonWisconsin, United States1CharlottesvilleVirginia, United States1Palo AltoCalifornia, United States1SpringfieldIllinois, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01859117 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.